CD40 抗体 (AA 35-84)
-
- 抗原 See all CD40 抗体
- CD40
-
抗原表位
- AA 35-84
-
适用
- 人, 兔, 猴, Pig
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This CD40 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 特异性
- Human CD40
- 预测反应
- Percent identity by BLAST analysis: Human (100%) Guinea pig (90%) Pig (83%).
- 纯化方法
- Immunoaffinity purified
- 免疫原
-
Synthetic peptide located between aa35-84 of human CD40 (P25942, NP_690593). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Monkey, Marmoset, Rabbit (100%), Galago, Guinea pig (90%), Horse, Pig (83%).
Type of Immunogen: Synthetic peptide - 亚型
- IgG
- Top Product
- Discover our top product CD40 Primary Antibody
-
-
- 应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:62500.
Not recommended for: IHC-P - 说明
-
Target Species of Antibody: Human
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Distilled water
- 浓度
- Lot specific
- 缓冲液
- Lyophilized from PBS with 2 % sucrose
- 注意事项
- Avoid repeat freeze-thaw cycles.
- 储存条件
- 4 °C,-20 °C
- 储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- 抗原
- CD40
- 别名
- CD40 (CD40 产品)
- 别名
- Bp50 antibody, CDW40 antibody, TNFRSF5 antibody, p50 antibody, AI326936 antibody, GP39 antibody, HIGM1 antibody, IGM antibody, IMD3 antibody, T-BAM antibody, TRAP antibody, Tnfrsf5 antibody, TNFSF5 antibody, CD40 molecule antibody, CD40 antigen antibody, CD40 antibody, Cd40 antibody
- 背景
-
Name/Gene ID: CD40
Family: TNF Receptor
Synonyms: CD40, B-cell surface antigen CD40, B cell-associated molecule, B cell surface antigen CD40, CD40 antigen, CD40 type II isoform, p50, Bp50, CD40L receptor, CDW40, TNFRSF5 - 基因ID
- 958
- NCBI登录号
- NP_690593
- UniProt
- P25942
- 途径
- NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-